START OF PAGE 1
HOUSE BILL 808

J1 6lr3117
CF SB 490

By: Delegate S. Johnson
Introduced and read first time: February 4, 2026
Assigned to: Health

A BILL ENTITLED

1 AN ACT concerning

2 Maryland Medical Assistance Program – Step Therapy, Fail–First Protocols, and
3 Prior Authorization – Prescription Drugs to Treat Serious Mental Illness

4 FOR the purpose of prohibiting the Maryland Medical Assistance Program from applying
5 a prior authorization requirement in certain circumstances to and from applying a
6 step therapy or fail–first protocol for a prescription drug used to treat an adult
7 enrollee’s diagnosis of bipolar disorder, schizophrenia, major depression,
8 post–traumatic stress disorder, or a medication–induced movement disorder
9 associated with the treatment of serious mental illness; and generally relating to the
10 Maryland Medical Assistance Program and coverage of drugs to treat serious mental
11 illness.

12 BY adding to
13 Article – Health – General
14 Section 15–160
15 Annotated Code of Maryland
16 (2023 Replacement Volume and 2025 Supplement)

17 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
18 That the Laws of Maryland read as follows:

19 Article – Health – General

20 15–160.

21 (A) IN THIS SECTION, “STEP THERAPY OR FAIL–FIRST PROTOCOL” HAS THE
22 MEANING STATED IN § 15–142 OF THE INSURANCE ARTICLE.

EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law. *hb0808*
END OF PAGE 1

START OF PAGE 2
2 HOUSE BILL 808

1 (B) EXCEPT AS REQUIRED UNDER 42 U.S.C. § 1396A, BEGINNING JULY 1,
2 2026, THE PROGRAM MAY NOT APPLY A PRIOR AUTHORIZATION REQUIREMENT FOR
3 A PRESCRIPTION DRUG USED TO TREAT AN ADULT ENROLLEE’S DIAGNOSIS OF:

4 (1) BIPOLAR DISORDER;

5 (2) SCHIZOPHRENIA;

6 (3) MAJOR DEPRESSION;

7 (4) POST–TRAUMATIC STRESS DISORDER; OR

8 (5) A MEDICATION–INDUCED MOVEMENT DISORDER ASSOCIATED
9 WITH THE TREATMENT OF A SERIOUS MENTAL ILLNESS.

10 (C) BEGINNING JULY 1, 2026, THE PROGRAM MAY NOT APPLY A STEP
11 THERAPY OR FAIL–FIRST PROTOCOL FOR A PRESCRIPTION DRUG USED TO TREAT AN
12 ENROLLEE’S DIAGNOSIS OF:

13 (1) BIPOLAR DISORDER;

14 (2) SCHIZOPHRENIA;

15 (3) MAJOR DEPRESSION;

16 (4) POST–TRAUMATIC STRESS DISORDER; OR

17 (5) A MEDICATION–INDUCED MOVEMENT DISORDER ASSOCIATED
18 WITH THE TREATMENT OF A SERIOUS MENTAL ILLNESS.

19 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July
20 1, 2026. It shall remain effective for a period of 3 years and, at the end of June 30, 2029,
21 this Act, with no further action required by the General Assembly, shall be abrogated and
22 of no further force and effect.
END OF PAGE 2